share_log

4: Statement of changes in beneficial ownership of securities-Director McMullen Michael R.

SEC ·  Aug 1 08:16
Summary by Futu AI
Michael R. McMullen, associated with Bristol-Myers Squibb (BMY), was involved in a transaction with the company's stock on July 29, 2024. Specific details regarding the nature of the transaction, such as the action type, number of shares, transaction price, and the resulting ownership stake, were not disclosed in the announcement.
Michael R. McMullen, associated with Bristol-Myers Squibb (BMY), was involved in a transaction with the company's stock on July 29, 2024. Specific details regarding the nature of the transaction, such as the action type, number of shares, transaction price, and the resulting ownership stake, were not disclosed in the announcement.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.